A randomised phase III study in advanced oesophageal carcinoma to compare dysphagia in patients treated with radiotherapy versus chemo-radiotherapy.
People with cancer of the oesophagus (gullet) often have trouble swallowing. Radiotherapy can help improve this problem. Using chemotherapy together with radiotherapy may work better but has more side effects. This trial will determine if it is better to use radiotherapy by itself or together with chemotherapy.
Primary Sponsor
Trans Tasman Radiation Oncology Group (TROG)
Collaborating Groups
NCI CTG (ES 2)
Participating Centres
Final Accrual
220
Current Accrual
Trial Chairperson
Dr Michael Penniment, Royal Adelaide Hospital, SA
Trial Contact
sonya.stephens@health.sa.gov.au
Clinical Trial Registration
Related Post
February 28, 2022
Cancer trial participant hoping to help
The RAVES trial treating prostate cancer Participating in a
June 15, 2021
Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery
Ductal carcinoma in situ (DCIS) of the breast is
